These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 9160774)

  • 1. Blood pressure reactivity and vascular disease: call off the funeral.
    Spence JD
    Am J Hypertens; 1997 May; 10(5 Pt 1):582-3. PubMed ID: 9160774
    [No Abstract]   [Full Text] [Related]  

  • 2. Inappropriate priority claim.
    Messerli FH; Levy D
    J Hypertens; 2010 Aug; 28(8):1778; author reply 1778-9. PubMed ID: 20647862
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertension and left ventricular hypertrophy in the CAPD patient.
    Amann K; Mandelbaum A; Schwarz U; Ritz E
    Kidney Int Suppl; 1996 Nov; 56():S37-40. PubMed ID: 8914052
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac hypertrophy in hypertension: relation to 24-h blood pressure profile and arterial stiffness.
    Lekakis JP; Zakopoulos NA; Protogerou AD; Kotsis VT; Papaioannou TG; Stamatelopoulos KS; Tsitsiricos MD; Pitiriga VCh; Papamichael CM; Toumanides ST; Mavrikakis ME
    Int J Cardiol; 2004 Oct; 97(1):29-33. PubMed ID: 15336803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension.
    Stergiou GS; Argyraki KK; Moyssakis I; Mastorantonakis SE; Achimastos AD; Karamanos VG; Roussias LG
    Am J Hypertens; 2007 Jun; 20(6):616-21. PubMed ID: 17531917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-four-hour heart rate and blood pressure are additive markers of left ventricular mass in hypertensive subjects.
    Zakopoulos NA; Ikonomidis I; Vemmos KN; Manios E; Spiliopoulou I; Tsivgoulis G; Spengos K; Psaltopoulou D; Mavrikakis M; Moulopoulos SD
    Am J Hypertens; 2006 Feb; 19(2):170-7. PubMed ID: 16448887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory blood pressure monitoring in hemodialysis patients: a critique and literature review.
    Covic A; Haydar AA; Goldsmith D
    Semin Dial; 2004; 17(4):255-9. PubMed ID: 15250913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left-ventricular hypertrophy and coronary artery disease.
    Pierdomenico SD
    Am J Hypertens; 2007 Oct; 20(10):1036-7. PubMed ID: 17903684
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population.
    Kulah E; Dursun A; Aktunc E; Acikgoz S; Aydin M; Can M; Dursun A
    Blood Press Monit; 2007 Aug; 12(4):207-13. PubMed ID: 17625392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular hypertrophy: a potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure.
    Mansoor GA; Massie BM
    Blood Press Monit; 1999; 4 Suppl 1():S19-22. PubMed ID: 10822413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home BP for assessing haemodialysis hypertension.
    Agarwal R
    Nephrol Dial Transplant; 2007 Oct; 22(10):3089-90; author reply 3090. PubMed ID: 17636055
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular manifestations of autosomal dominant polycystic kidney disease in young adults.
    Handa SP
    Clin Invest Med; 2006 Dec; 29(6):339-46. PubMed ID: 17330449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalent influence of systolic over pulse pressure on left ventricular mass in essential hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Gattobigio R; Ambrosio G; Porcellati C
    Eur Heart J; 2002 Apr; 23(8):658-65. PubMed ID: 11969281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ambulatory pulse pressure and left ventricular hypertrophy in patients with essential hypertension].
    Cao Y; Zhao SP; Luo L
    Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):379-81. PubMed ID: 14653122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Masked hypertension: an independent predictor of organ damage.
    Cuspidi C; Parati G
    J Hypertens; 2007 Feb; 25(2):275-9. PubMed ID: 17211231
    [No Abstract]   [Full Text] [Related]  

  • 17. Twenty-four-hour mean heart rate and likelihood of left ventricular hypertrophy.
    Palmieri V
    Am J Hypertens; 2006 Feb; 19(2):178. PubMed ID: 16448888
    [No Abstract]   [Full Text] [Related]  

  • 18. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?
    Verdecchia P; Angeli F; Gattobigio R; Guerrieri M; Benemio G; Porcellati C
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S23-8. PubMed ID: 15592569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory blood pressure monitoring and target organ damage in pediatrics.
    Stabouli S; Kotsis V; Zakopoulos N
    J Hypertens; 2007 Oct; 25(10):1979-86. PubMed ID: 17885534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.